New data highlight off-the-shelf iPSC-derived CAR T-cell therapy for treatment-resistant systemic sclerosis

3 months ago 20
New preliminary objective information presented astatine ISSCR 2026 evaluated an induced pluripotent stem compartment (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a uncommon autoimmune illness with precocious mortality.
Read Entire Article